Mark Rothera Viracta Therapeutics, Inc. (VIRX) insider trading activity

VIRX Quotes by TradingView

Mark Rothera is President and CEO of Viracta Therapeutics, Inc.. Currently has a direct ownership of 100,000 shares of VIRX, which is worth approximately $54,000. The most recent transaction as insider was on Dec 01, 2023, when has been sold 47,906 shares (Common Stock) at a price of $0.49 per share, resulting in proceeds of $23,473. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K
0% 3M change
n/a 12M change
Total Value Held $54,000

Mark Rothera Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2023
BUY
Open market or private purchase
$23,473 $0.49 p/Share
47,906 Added 32.39%
100,000 Common Stock
Nov 30 2023
BUY
Open market or private purchase
$25,526 $0.49 p/Share
52,094 Added 50.0%
52,094 Common Stock
MR

Mark Rothera

President and CEO
Cardiff, CA

Track Institutional and Insider Activities on VIRX

Follow Viracta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIRX shares.

Notify only if

Insider Trading

Get notified when an Viracta Therapeutics, Inc. insider buys or sells VIRX shares.

Notify only if

News

Receive news related to Viracta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIRX